These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14437446)

  • 1. An in vivo test for measuring monoamine oxidase inhibition in human subjects.
    RESNICK O; HAGOPIAN M; HOAGLAND H; FREEMAN H
    AMA Arch Gen Psychiatry; 1960 Apr; 2():459-61. PubMed ID: 14437446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with iproniazid and additional monoamine oxidase inhibitors with analogous effects].
    VOELKEL A
    Psychiatr Neurol (Basel); 1960 Jul; 140():83-8. PubMed ID: 13781777
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial treatment with Catran in chronic mental patients. Preliminary report].
    WICKSTROM L
    Sven Lakartidn; 1960 Nov; 57():3374-8. PubMed ID: 13785007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences in the 1 to 2 year treatment of chronic psychiatric patients with MAO inhibitors].
    WICKSTROM L
    Sven Lakartidn; 1961 Mar; 58():664-8. PubMed ID: 13785006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychosurgery permits the cure of patients].
    COSSA P
    Med Hyg (Geneve); 1952 Feb; 10(211):39-40. PubMed ID: 14956252
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 9. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 11. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R
    Rev Asoc Medica Mex; 1960 Jun; 40():272-9. PubMed ID: 14426018
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of intrafrontal injection of own blood as a variant of leukotomy].
    SPERLING E
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1953; 190(5):377-88. PubMed ID: 13092918
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
    GENOVESE E; ARRIGONI-MARTELLI E; FRESIA P
    Farmaco Sci; 1959 Jul; 14():516-26. PubMed ID: 13849925
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of microdoses of Aminazin on healthy and psychic subjects].
    SKRIABIN GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1962; 62():219-22. PubMed ID: 13913713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications for psychotherapy in the treatment of psychoses].
    PORTA V
    Arch Psicol Neurol Psichiatr; 1961; 22():447-58. PubMed ID: 14488046
    [No Abstract]   [Full Text] [Related]  

  • 18. [Somatic therapy of endogenous psychoses].
    EDERLE W
    Med Monatsschr; 1948 Aug; 2(8):292-4. PubMed ID: 18886919
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined coramine-glissando electroconvulsive therapy in severe psychotic excitement.
    LEISER R; IZNER SM
    J Nerv Ment Dis; 1953 Apr; 117(4):353-5. PubMed ID: 13085187
    [No Abstract]   [Full Text] [Related]  

  • 20. [On a new psychopharmacon (chlorprothixen) in the treatment of endogenous psychoses].
    MUELLER D
    Psychiatr Neurol Med Psychol (Leipz); 1961 May; 13():184-93. PubMed ID: 13773462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.